Pyxis (PYXS) is a preclinical oncology company developing next-gen therapeutics. Dr. Lara Sullivan, Chief Executive Officer of Pyxis, discusses what’s next for Pyxis. She talks about Pyxis’ notable partners such as Pfizer (PFE), Alloy Therapeutics, and Legochem Biotherapeutics. Tune in to find out more.
02 Dec 2021
The Watch List
28 Apr 2022
The Watch List
20 Apr 2022
Morning Trade Live
18 Mar 2022
The Watch List
01 Mar 2022
Trading 360
18 Apr 2022
The Watch List
13 May 2022